PPAR-γ partial agonists in disease-fate decision with special reference to cancer
Peroxisome proliferator-activated receptor-γ (PPAR-γ) has emerged as one of the most
extensively studied transcription factors since its discovery in 1990, highlighting its …
extensively studied transcription factors since its discovery in 1990, highlighting its …
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
A large body of evidence indicates the existence of a complex pathophysiological
relationship between cardiovascular diseases and cancer. Mitochondria are crucial …
relationship between cardiovascular diseases and cancer. Mitochondria are crucial …
Discovery of a novel 1, 3, 4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental …
S Gastaldi, C Rocca, E Gianquinto, MC Granieri… - European Journal of …, 2023 - Elsevier
Inspired by the recent advancements in understanding the binding mode of sulfonylurea-
based NLRP3 inhibitors to the NLRP3 sensor protein, we developed new NLRP3 inhibitors …
based NLRP3 inhibitors to the NLRP3 sensor protein, we developed new NLRP3 inhibitors …
Current status and future perspectives on therapeutic potential of apigenin: Focus on metabolic-syndrome-dependent organ dysfunction
Metabolic syndrome and its associated disorders such as obesity, insulin resistance,
atherosclerosis and type 2 diabetes mellitus are globally prevalent. Different molecules …
atherosclerosis and type 2 diabetes mellitus are globally prevalent. Different molecules …
Mitochondrial determinants of anti-cancer drug-induced cardiotoxicity
Mitochondria are key organelles for the maintenance of myocardial tissue homeostasis,
playing a pivotal role in adenosine triphosphate (ATP) production, calcium signaling, redox …
playing a pivotal role in adenosine triphosphate (ATP) production, calcium signaling, redox …
From energy metabolic change to precision therapy: a holistic view of energy metabolism in heart failure
J Wen, C Chen - Journal of Cardiovascular Translational Research, 2024 - Springer
Heart failure (HF) is a complex and multifactorial disease that affects millions of people
worldwide. It is characterized by metabolic disturbances of substrates such as glucose, fatty …
worldwide. It is characterized by metabolic disturbances of substrates such as glucose, fatty …
Deacetylase‐dependent and‐independent role of HDAC3 in cardiomyopathy
J Ren, Q Zeng, H Wu, X Liu, MC Guida… - Journal of cellular …, 2023 - Wiley Online Library
Cardiomyopathy is a common disease of cardiac muscle that negatively affects cardiac
function. HDAC3 commonly functions as corepressor by removing acetyl moieties from …
function. HDAC3 commonly functions as corepressor by removing acetyl moieties from …
Quercetin and its derivative counteract palmitate-dependent lipotoxicity by inhibiting oxidative stress and inflammation in cardiomyocytes
MC Granieri, C Rocca, A De Bartolo, IC Nettore… - International Journal of …, 2023 - mdpi.com
Cardiac lipotoxicity plays an important role in the pathogenesis of obesity-related
cardiovascular disease. The flavonoid quercetin (QUE), a nutraceutical compound that is …
cardiovascular disease. The flavonoid quercetin (QUE), a nutraceutical compound that is …
[HTML][HTML] NLRP3 inflammasome as a novel therapeutic target for heart failure
S Wang, J Zhang, Y Wang, X Jiang… - Anatolian Journal of …, 2022 - ncbi.nlm.nih.gov
Heart failure (HF) is a leading cause of mortality worldwide. The pathogenesis of HF is
complex and has not yet been fully elucidated, which has slowed drug development and …
complex and has not yet been fully elucidated, which has slowed drug development and …
Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience)
ZN Klashami, MG Roudbordeh, M Asadi… - Molecular Biology …, 2023 - Springer
Abstract Introduction Angiotensin Converting Enzyme or ACE is an exo-peptidase that
causes the conversion of angiotensin I to angiotensin II, vasoconstriction, and aldosterone …
causes the conversion of angiotensin I to angiotensin II, vasoconstriction, and aldosterone …